Cargando…

Disproportionality analysis of anaphylactic reactions after vaccination with messenger RNA coronavirus disease 2019 vaccines in the United States

Detalles Bibliográficos
Autores principales:	Rodriguez-Nava, Guillermo, Egoryan, Goar, Trelles-Garcia, Daniela Patricia, Yanez-Bello, Maria Adriana, Murguia-Fuentes, Ricardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8026243/ https://www.ncbi.nlm.nih.gov/pubmed/33838338 http://dx.doi.org/10.1016/j.anai.2021.04.004

Ejemplares similares

CHARACTERIZATION OF THE FIRST 391 REPORTS OF MYOCARDITIS AFTER MRNA COVID-19 VACCINES SUBMITTED TO THE VACCINE ADVERSE EVENT REPORTING SYSTEM - UNITED STATES
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

Development of cavitary lung disease as a long-term complication of coronavirus disease 2019 in a young previously healthy patient: a case report
por: Egoryan, Goar, et al.
Publicado: (2021)

Posterior reversible encephalopathy syndrome in a patient with Richter's syndrome on combination DA-R-EPOCH chemotherapy regimen: a case report
por: Egoryan, Goar, et al.
Publicado: (2021)

2341. Response to Vaccination Against COVID-19 in a Community Oncology Practice: a Rational for Antibody Testing
por: Egoryan, Goar, et al.
Publicado: (2023)

A Retrospective Study of Coinfection of SARS-CoV-2 and Streptococcus pneumoniae in 11 Hospitalized Patients with Severe COVID-19 Pneumonia at a Single Center
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2020)

MMR Vaccine Adverse Drug Reactions Reports in the CDC WONDER System, 1989–2019
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2020)

THE FIRST AND SECOND WAVES OF THE COVID-19 PANDEMIC IN A COMMUNITY HOSPITAL ICU
por: RODRIGUEZ-NAVA, GUILLERMO, et al.
Publicado: (2021)

Comparison of clinical characteristics and outcomes of hospitalized patients with seasonal coronavirus infection and COVID-19: a retrospective cohort study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2022)

EXPERIENCE WITH REMDESIVIR FOR THE TREATMENT OF CRITICAL COVID-19 IN A COMMUNITY-BASED HOSPITAL IN EVANSTON, ILLINOIS
por: EGORYAN, GOAR, et al.
Publicado: (2021)

An overlooked cause of septic shock: Staphylococcal Toxic Shock Syndrome secondary to an axillary abscess
por: Poudel, Bidhya, et al.
Publicado: (2020)

551. Remdesivir and Tocilizumab for the Treatment of Severe COVID-19 in a Community Hospital: A Retrospective Cohort Study
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2021)

Coronavirus Disease 2019 Messenger RNA Vaccine Immunogenicity in Immunosuppressed Individuals
por: Collier, Ai-ris Y, et al.
Publicado: (2021)

2175. Diagnostic Utility of Pneumococcal Urinary Antigen Assay in Clinical Practice: a Retrospective Study in a Community Hospital in Evanston, Illinois
por: Egoryan, Goar, et al.
Publicado: (2022)

Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
por: Kohli-Pamnani, Anita, et al.
Publicado: (2022)

Anaphylactic reactions after COVID-19 vaccination in Germany
por: Barth, Immanuel, et al.
Publicado: (2023)

423. Development and Validation of a Predictive Model of New-Onset Deep Vein Thrombosis/Pulmonary Embolism Among Hospitalized COVID-19 Patients: A Retrospective Cohort Study
por: Meng, Qingqing, et al.
Publicado: (2023)

Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions
por: Pitlick, Mitchell M., et al.
Publicado: (2022)

Clinical characteristics and outcomes of the first two waves of the COVID-19 pandemic in a community hospital: a retrospective cohort study
por: Egoryan, Goar, et al.
Publicado: (2022)

Adverse Reactions after BNT162b2 Messenger RNA Vaccination for Coronavirus Disease 2019 in Healthcare Workers Compared with Influenza Vaccination
por: Kim, A-Sol, et al.
Publicado: (2023)

Outcomes of allergic-type reactions after messenger RNA coronavirus disease 2019 vaccination at 3 military medical centers
por: St. Clair, Benjamin D., et al.
Publicado: (2022)

Antibody response to graded dosing of coronavirus disease 2019 messenger RNA vaccines after allergic reaction to first dose
por: Van Meerbeke, Sara W., et al.
Publicado: (2022)

Anaphylactic shock following the diagnosis of coronavirus disease 2019
por: Alvarez-Perea, Alberto, et al.
Publicado: (2020)

Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 Vaccine( )
por: Maron, Jenny S, et al.
Publicado: (2022)

Skin Adverse Reactions to Novel Messenger RNA Coronavirus Vaccination: A Case Series
por: Peigottu, Maria Francesca, et al.
Publicado: (2021)

Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
por: de Chaisemartin, Luc, et al.
Publicado: (2022)

Effectiveness of Messenger RNA-1273 Vaccine Booster Against Coronavirus Disease 2019 in Immunocompetent Adults
por: Florea, Ana, et al.
Publicado: (2022)

Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data
por: Boufidou, Fotini, et al.
Publicado: (2023)

Evaluation of anaphylaxis risk by skin testing with coronavirus disease 2019 messenger RNA vaccines on patients with anaphylaxis
por: Pienkowski, Marek M., et al.
Publicado: (2022)

Myopericarditis after messenger RNA Coronavirus Disease 2019 Vaccination in Adolescents 12 to 18 Years of Age
por: Das, Bibhuti B., et al.
Publicado: (2021)

Long-term evaluation of sperm parameters after coronavirus disease 2019 messenger ribonucleic acid vaccination
por: Diaz, Parris, et al.
Publicado: (2022)

Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
por: Su, Wei-Ju, et al.
Publicado: (2023)

Anti-NMDA receptor encephalitis and vaccination: A disproportionality analysis
por: Martin, Salomé, et al.
Publicado: (2022)

Advances in medicine and positive natural selection: Prosthetic valve endocarditis due to biofilm producer Micrococcus luteus
por: Rodriguez-Nava, Guillermo, et al.
Publicado: (2020)

Anaphylactic reactions to mRNA COVID-19 vaccines: A call for further study
por: Hatziantoniou, Sophia, et al.
Publicado: (2021)

Reverse Takotsubo Cardiomyopathy Following COVISHIELD Vaccination: A Rare Case of an Anaphylactic Reaction
por: Shah, Mandar M, et al.
Publicado: (2023)

Hypersensitivity reactions following the Moderna messenger RNA-1273 vaccine
por: Drohan, Alex, et al.
Publicado: (2021)

Severe anaphylactic reaction to atracurium
por: Gupta, Amrita, et al.
Publicado: (2012)

Anaphylactic reaction to intravenous diclofenac
por: Singh, Ranju, et al.
Publicado: (2011)

Anaphylactic reactions presenting with hypertension
por: Solmazgul, Emrullah, et al.
Publicado: (2016)

Dangerous anaphylactic reaction to mustard
por: Pałgan, Krzysztof, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jtq8f0iqjmuhi1paj31iplsfpc